FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE: Safety Overview
| Metric | FOSAPREPITANT | FOSFOMYCIN TROMETHAMINE |
|---|---|---|
| Total FAERS Reports | 487 | 778 |
| Deaths Reported | 154 | 24 |
| Death Rate | 31.6% | 3.1% |
| Hospitalizations | 264 | 280 |
| Average Patient Age | 49.6 yrs | 59.2 yrs |
| % Female Patients | 83.0% | 83.9% |
| FDA Approval Date | N/A | Dec 19, 1996 |
| Manufacturer | N/A | Cipla USA Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Discontinued |